| 601 | CODXCo-Diagnostics, Inc. |
$622.5K |
-7,533.6% |
2025 |
| 602 | SPAISafe Pro Group Inc. |
$606.7K |
-2,360.8% |
2025 |
| 603 | YDESYD Bio Ltd |
$596.8K |
-1,392.6% |
2025 |
| 604 | CRDFCardiff Oncology, Inc. |
$593K |
-7,732.0% |
2025 |
| 605 | ELABPMGC Holdings Inc. |
$590.1K |
-1,313.0% |
2025 |
| 606 | YARWYarrow Bioscience, Inc. |
$570K |
-4,646.1% |
2025 |
| 607 | QUCYQuantum Cyber N.V. |
$537.1K |
-3,018.3% |
2025 |
| 608 | LIPOLipella Pharmaceuticals Inc. |
$536.4K |
-935.2% |
2024 |
| 609 | ITOCiTonic Holdings Ltd |
$523K |
-974.7% |
2025 |
| 610 | MREOMereo BioPharma Group plc |
$500K |
-8,375.6% |
2025 |
| 611 | MGRXMangoceuticals, Inc. |
$456K |
-4,526.8% |
2025 |
| 612 | XTLBXtl Biopharmaceuticals Ltd |
$451K |
-227.7% |
2024 |
| 613 | SCNXScienture Holdings, Inc. |
$431.6K |
-9,618.0% |
2025 |
| 614 | MNOVMedicinova Inc |
$409.7K |
-2,928.8% |
2025 |
| 615 | CANFCan-Fite BioPharma Ltd. |
$405K |
-2,426.7% |
2025 |
| 616 | ADXNAddex Therapeutics Ltd. |
CHF 404.1K |
1,746.0% |
2024 |
| 617 | BRTXBioRestorative Therapies, Inc. |
$359.7K |
-3,959.4% |
2025 |
| 618 | PLSEPulse Biosciences, Inc. |
$350K |
-20,794.6% |
2025 |
| 619 | ALLRAllarity Therapeutics, Inc. |
$320K |
-3,509.7% |
2025 |
| 620 | HINDVyome Holdings, Inc |
$319.7K |
-3,209.7% |
2025 |
| 621 | NXLNexalin Technology, Inc. |
$301.6K |
-2,725.8% |
2025 |
| 622 | ABVCAbvc Biopharma, Inc. |
$296K |
-2,671.8% |
2025 |
| 623 | QTEXQTREX Quantum Ltd. |
$289K |
-4,574.4% |
2025 |
| 624 | GDTCCytoMed Therapeutics Ltd |
$252.3K |
-1,227.1% |
2025 |
| 625 | COCHEnvoy Medical, Inc. |
$241K |
-9,857.3% |
2025 |
| 626 | SKYASkyAI, Inc. |
$204.1K |
-138,400.0% |
2025 |
| 627 | CLNNClene Inc. |
$200K |
-13,086.5% |
2025 |
| 628 | ATYRaTYR PHARMA INC |
$190K |
-39,009.5% |
2025 |
| 629 | LSTALisata Therapeutics, Inc. |
$170K |
-9,756.5% |
2024 |
| 630 | VIVSVivoSim Labs, INC. |
$131K |
-10,567.2% |
2026 |
| 631 | SERSerina Therapeutics, Inc. |
$130K |
-14,755.4% |
2025 |
| 632 | AGPUAxe Compute Inc. |
$125.3K |
-186,053.4% |
2025 |
| 633 | BFRGBullFrog AI Holdings, Inc. |
$116.7K |
-5,569.6% |
2025 |
| 634 | IBIOiBio, Inc. |
$100K |
-33,044.0% |
2026 |
| 635 | ATNMActinium Pharmaceuticals, Inc. |
$90K |
-37,652.2% |
2025 |
| 636 | AIMAIM ImmunoTech Inc. |
$88K |
-15,861.4% |
2025 |
| 637 | SERASera Prognostics, Inc. |
$81K |
-39,417.3% |
2025 |
| 638 | ACONAclarion, Inc. |
$75.7K |
-9,551.9% |
2025 |
| 639 | SILOSilo Pharma, Inc. |
$72.1K |
-5,863.5% |
2025 |
| 640 | PAVMPAVmed Inc. |
$71K |
564.8% |
2025 |
| 641 | INOInovio Pharmaceuticals, Inc. |
$65.3K |
-130,000.0% |
2025 |
| 642 | CNTBConnect Biopharma Holdings Ltd |
$64K |
-86,687.5% |
2025 |
| 643 | AVTXAvalo Therapeutics, Inc. |
$59K |
-132,642.4% |
2025 |
| 644 | HCWBHCW Biologics Inc. |
$54.2K |
-14,677.1% |
2025 |
| 645 | INMBInmune Bio, Inc. |
$50K |
-91,866.0% |
2025 |
| 646 | ENTXEntera Bio Ltd. |
$42K |
-27,235.7% |
2025 |
| 647 | KZIAKazia Therapeutics Ltd |
A$42K |
-49,290.5% |
2025 |
| 648 | ALTAltimmune, Inc. |
$41K |
-214,861.0% |
2025 |
| 649 | NTHINeonc Technologies Holdings, Inc. |
$40K |
-155,404.4% |
2025 |
| 650 | CUPRCuprina Holdings (Cayman) LTD |
$38.8K |
-9,366.7% |
2025 |